On 2025-03-10, Alzamend Neuro, Inc. (ALZN) announced earnings per share of $-1.71 for the fiscal quarter ending 2025-01-31, beating the average analyst estimate of $-2.61.
The next expected annoucement date for quarterly earnings is 2025-07-29, with an average estimated earnings per share of $-2.70 for the fiscal quarter ending 2025-04-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-03-10 | 2025-01-31 | $-2.61 | $-1.71 |
| 2024-12-11 | 2024-10-31 | $-21.42 | $-3.60 |
| 2024-09-11 | 2024-07-31 | -- | $-11.25 |
| 2024-03-25 | 2024-01-31 | -- | $-34.20 |
| 2023-12-15 | 2023-10-31 | -- | $39.60 |
| 2023-09-13 | 2023-07-31 | -- | $-53.98 |
| 2023-07-27 | 2023-04-30 | -- | $-40.48 |
| 2023-03-16 | 2023-01-31 | -- | $-80.97 |
| 2022-12-12 | 2022-10-31 | -- | $-40.48 |
| 2022-09-13 | 2022-07-31 | -- | $-40.48 |
| 2022-07-19 | 2022-04-30 | -- | $-67.47 |
| 2022-03-15 | 2022-01-31 | $-26.99 | $-40.48 |
| 2021-12-13 | 2021-10-31 | $-26.99 | $-53.98 |
| 2021-09-13 | 2021-07-31 | -- | $-40.48 |